ARCHIVES

FDA Ponders Standards For “Retrospective Prospective” Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Varmus: NCI Needs To Rethink, Review; Programs Must Be “At A High Level”

November 12, 2010

Study: Oncotype DX Score Can Predict Local Recurrence

March 29, 2013

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

NCI CTEP Approved Trials For the Month of November

November 29, 2013

NCI Begins Ovarian Cancer Trial To Build Blood Samples

October 28, 2005

Coalition Opens Web Site To Promote Cancer Trials.

June 15, 2001